Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:00 AM
Ignite Modification Date:
2025-12-25 @ 12:00 AM
NCT ID:
NCT00004058
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Histologically proven relapsed or refractory hematologic malignancy or bone marrow disorder for which there is no standard curative therapy, including, but not limited to:
* Myelodysplasia
* Multiple myeloma
* Myeloproliferative syndrome
* Chronic lymphocytic leukemia
* Aplastic anemia
* Non-Hodgkin's lymphoma
* Acute leukemia
* Hodgkin's lymphoma
* Chronic myelogenous leukemia
PATIENT CHARACTERISTICS:
Age:
* Over 18
Performance status:
* ECOG 0-2
Life expectancy:
* Greater than 1 month
Hematopoietic:
* Not specified
Hepatic:
* Bilirubin no greater than 1.5 times upper limit of normal (ULN)
* AST no greater than 3 times ULN
Renal:
* Creatinine no greater than 2.0 mg/dL
Cardiovascular:
* Cardiac ejection fraction greater than 40%
Pulmonary:
* FEV\_1 greater than 50% predicted
Other:
* No active infection
* Not pregnant or nursing
* Negative pregnancy test
* Fertile patients must use effective contraception during and for 10 weeks after study participation
* No uncontrolled psychiatric or medical illness
PRIOR CONCURRENT THERAPY:
Biologic therapy:
* Greater than 3 weeks since prior biologic therapy
Chemotherapy:
* Greater than 3 weeks since prior chemotherapy and recovered
Endocrine therapy:
* Not specified
Radiotherapy:
* Not specified
Surgery:
* Not specified
Other:
* No other concurrent investigational agents
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00004058
Study Brief:
Protocol Section:
NCT00004058